Open access
Aug 2026
Magnolol Potentiates Sorafenib-induced Apoptosis and Inhibits Metastatic Signaling in Renal Carcinoma
Background/Aim: Sorafenib is a standard targeted therapy for renal cell carcinoma; however, resistance and limited efficacy remain clinical challenges. Magnolol, a bioactive compound derived from Magnolia officinalis, exhibits anti-cancer properties, and may enhance therapeutic responses. This study investigated whethe...
Che-Cheng Chang, Man-Yun Hung, Yueh-Shan Weng et al.
· In Vivo · 0 citations